Prevention of glutamate neurotoxicity in cultured neurons by 3,4-dihydro-6-hydroxy-7-methoxy-2,2-dimethyl-1(2H)-benzopyran (CR-6), a scavenger of nitric oxide
摘要:
Glutamate neurotoxicity in cerebellar neurons in culture is mediated by excessive production of nitric oxide (NO). We anticipated that 3,4-dihydro 6-hydroxy-7-methoxy-2,2-dimethyl-1(2H) -benzopyran (CR-6) could act as a scavenger of NO since it contains a position (C-5) highly activated towards nitration reaction. The aim of this work was to assess whether CR-6 acts as an NO scavenger and prevents glutamate neurotoxicity in cultures of cerebellar neurons. It was shown that CR-6 reduced, in a dose-dependent manner, glutamate-induced formation of cGMP (EC50 approximate to 15 mu M) and prevented glutamate neurotoxicity. The protection was approximate to 50% at 3-10 mu M and nearly complete at 100 mu M. CR-6 did not prevent glutamate-induced activation of NO synthase, but interfered with the glutamate-NO-cGMP pathway at a later step. CR-6 reduced the formation of cGMP induced by S-nitroso-N-acetylpenicillamine (SNAP), an NO-generating agent, indicating that CR-6 acts as a scavenger of NO in cultured neurons. This was further supported by experiments showing that in neurons treated with CR-6 and glutamate, the 5-nitro derivative of CR-6 was formed, as determined by GC-MS analyses. Moreover, in vitro incubation of CR-6 with SNAP also produced the 5-nitroderivative, thus confirming that CR-6 directly reacts with NO. The results reported indicate that CR-6 acts as an NO scavenger in neurons and prevents glutamate neurotoxicity. (C) 1999 EIsevier Science Inc.
Suggested is a cosmetic compositions comprising
(a) a crosspolymer obtained from copolymerisation of at least two different polyols and at least one dicarboxylic acid and
(b) at least one fragrance.
The present invention is directed towards the use of substituted chroman-6-ols of formula (I) wherein R
1
and R
2
are independently from each other H or C
1-11
-alkyl or (CH
2
)
n
—OH with n being an integer from 1 to 4, or R
1
and R
2
represent together a keto group, 10 A is CHR
3
or C(═O), and wherein R
3
, R
4
and R
6
are independently from each other H or C
1-4
-alkyl, and wherein R
5
is H or OH or C
1-4
-alkyl or C
1-4
-alkoxy, as antioxidants, especially in feed such as pet food and feed ingredients such as fish meal, insect meal and poultry meal, as well as PUFA-containing oil such as marine oil, microbial oil, fungal oil, algal oil and PUFA-containing plant oil. The present invention is further directed towards feed ingredients and feed for insects, aquatic and terrestrial animals comprising such substituted chroman-6-ols of formula (I).
A study of the reaction of different phenol substrates with nitric oxide and peroxynitrite
作者:Susana Yenes、Angel Messeguer
DOI:10.1016/s0040-4020(99)00877-7
日期:1999.12
investigated. In general, nitration is the major reaction with peroxynitrite, while reactions with aqueous solutions of nitric oxide led to mixtures of nitro and nitroso derivatives depending upon the phenol. Nitrosation occurs on phenol substrates bearing a free para- position with respect to the OH group with the exception of 1-naphthol, which afforded a 1:1 mixture of the 2- and the 4-nitroso derivatives
COMPOUNDS FOR PREVENTING, REDUCING AND/OR ALLEVIATING ITCHY SKIN CONDITION(S)
申请人:SCHMAUS Gerhard
公开号:US20160008297A1
公开(公告)日:2016-01-14
The present invention primarily relates to the use of one or more specific compounds and/or one or more respective salt(s) thereof for preventing, reducing or alleviating itchy skin condition(s), and/or as PAR-2 antagonist. Furthermore, the present invention relates to compositions (products or, respectively, formulations), in particular for topical administration, preferably cosmetic or pharmaceutical compositions, in particular for preventing, reducing or alleviating one or more itchy skin conditions and/or for providing a PAR-2 antagonistic effect, comprising or consisting of an effect amount of such compound(s) and/or salt(s) and one or more cosmetically and/or pharmaceutically acceptable carriers.
USE OF DIHYDRODEHYDRODIISOEUGENOL AND PREPARATIONS COMPRISING DIHYDRODEHYDRODIISOEUGENOL
申请人:Meyer Imke
公开号:US20130101650A1
公开(公告)日:2013-04-25
This invention relates to cosmetic and pharmaceutical preparations comprising
(i) a diastereomer or a mixture of two or more diastereomers of the compound of formula (I)
or
(ii) a salt of a diastereomer or of a mixture of two or more diastereomers of the compound of formula (I) or
(iii) a mixture of two or more salts of a diastereomer or of a mixture of two or more diastereomers of the compound of formula (I),
a diastereomer, salt or a mixture as defined above as a drug for topical application and/or for the treatment of lipoatrophy;
the non-therapeutic use of a diastereomer, salt or a mixture as defined above for the prevention, treatment or reduction of skin aging, especially skin wrinkles;
the use of a diastereomer, salt or a mixture as defined above for the production of an orally administered non-pharmaceutical preparation.